SecBot SecBot
8-K ·Filed Jul 20, 2026

NEO

NEOGENOMICS INC
NEUTRAL
Impact 4/10
Horizonimmediate Processed3mo ago SEC0001077183-26-000045
8-K context-dependent: Items 7.01, 8.01
Actionable Insight • Neutral

The settlement removes a known legal overhang at a cost below the reserved amount, which is slightly positive for the balance sheet. However, the matter was already disclosed and accrued, so no material change to the investment thesis. Monitor for any additional regulatory developments, but the resolution is a neutral event with no immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
NEO ▲ +15.29% at T+60d
NEUTRAL call +15.29% · α vs SPY +11.32% · entry $14.45 → $16.66
Entry = T+0 close
Jul 20, 2026
via day close
T+1d
-3.04%
call -3.04% · α -2.93%
$14.01
settled 3mo ago
T+5d
-9.07%
call -9.07% · α -7.84%
$13.14
settled 3mo ago
T+20d
+10.03%
call +10.03% · α +7.47%
$15.90
settled 2mo ago
T+60d
+15.29%
call +15.29% · α +11.32%
$16.66
settled 14d ago

Price Chart

Loading chart...

Executive Summary

NeoGenomics finalized a civil settlement with the DOJ for $9.8M, resolving a legacy investigation into consulting services related to its Laboratory Collaboration Initiative. The settlement amount is below the previously accrued $11.2M reserve, removing legal overhang without requiring additional cash. The resolution is a clean-up of a known liability and carries no admission of liability.

Key Facts

  • Settlement amount of $9,813,260 plus 4.250% interest from January 16, 2026
  • Previously accrued reserve of $11.2 million as of March 31, 2026
  • Voluntary self-disclosure to OIG-HHS in November 2021
  • No admission of liability by the Company
  • Resolution of U.S. government investigation into consulting services for laboratory testing

Financial Impact

Settlement of $9.8M is $1.4M below the $11.2M reserve, resulting in a modest release of excess reserves

cashlegal reserves

Risk Factors

  • Further regulatory scrutiny or follow-on private litigation could arise despite the settlement
  • Interest on the settlement amount adds $0.3M+ to total cost

Market Snapshot

Exchange
Nasdaq
Sector
Services-Testing Laboratories
Analyst Consensus
69% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001077183-26-000045
Document: a2026-07x20pressrelease.htm0001077183-26-000045
Document: 0001077183-26-000045-index-headers.html0001077183-26-000045
Document: 0001077183-26-000045-index.html0001077183-26-000045
Document: 0001077183-26-000045.txt0001077183-26-000045
4 reports for NEO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for NEO — sortable, filterable
TypeNow
Oct 5, 2026
21d ago
8-K
MIXED ★ 5/10
$16.51awaiting T+60—$16.69 (+1.12%)
Jul 20, 2026
14w ago
8-K
NEUTRAL ★ 4/10
$14.45 $16.66▲ +15.29%▲ +11.32%$16.69 (+15.50%)
May 22, 2026
22w ago
8-K
NEUTRAL ★ 2/10
$9.27 $16.66▲ +79.67%▲ +76.94%$16.69 (+80.04%)
Apr 28, 2026
25w ago
8-K
BULLISH ★ 6/10
$8.96 $13.89▲ +55.02%▲ +50.91%$16.69 (+86.27%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 5h 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026